Order results by:
| Issue | Title | |
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... Aim. To study the effect of replacing clopidogrel with ticagrelor on endpoints of hospital period ..." | ||
| Vol 13, No 6 (2017) | CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE | Abstract similar documents |
| A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina | ||
| "... .5%) patients received clopidogrel, 17 (16.5%) – ticagrelor. After therapy correction based on genotype GA ..." | ||
| Vol 16, No 6 (2020) | Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice? | Abstract similar documents |
| T. M. Uskach, A. S. Tereshchenko | ||
| "... to clopidogrel. The comparison of prasugrel versus ticagrelor (ISAR-REACT 5 trial) demonstrated superiority ..." | ||
| Vol 14, No 6 (2018) | P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel | Abstract PDF (Eng) similar documents |
| N. M. Vorobyeva | ||
| "... with clopidogrel or ticagrelor was performed, as well as of all 3 P2Y12-receptor inhibitors among themselves ..." | ||
| Vol 18, No 5 (2022) | The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case | Abstract similar documents |
| O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova | ||
| "... Background. Combination therapy with two antiplatelet agents (ticagrelor or clopidogrel plus ..." | ||
| Vol 6, No 4 (2010) | CLOPIDOGREL PHARMACOGENETICS | Abstract similar documents |
| A. N. Meshkov | ||
| "... agents all over the world is clopidogrel, R2Y12-receptor blocker. It is shown that clopidogrel has ..." | ||
| Vol 6, No 2 (2010) | THE MODERN ASPECTS OF CLOPIDOGREL USE | Abstract similar documents |
| E. N. Dankovtseva, D. A. Zateyshchikov | ||
| "... The possibilities and evidence base of clopidogrel use in clinical practice are discussed. Data ..." | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract similar documents |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| "... Aim. To analyze the literary and own data about clopidogrel influence on platelets during ..." | ||
| Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. V. Rudakova, N. V. Lomakin | ||
| "... years. It was assumed that the patients were receiving either generic clopidogrel or ticagrelor for 1 ..." | ||
| Vol 14, No 2 (2018) | WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| M. Yu. Gilyarov, Е. V. Konstantinova | ||
| "... of reperfusion and the selected treatment strategy. Due to some limitations in the use of clopidogrel ..." | ||
| Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
| I. S. Yavelov | ||
| "... , ticagrelor, in patients with high risk of thrombotic complications of atherosclerosis with a history ..." | ||
| Vol 8, No 4 (2012) | ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin | ||
| "... agents is discussed, especially this for ticagrelor which is the first-line drug in acute coronary ..." | ||
| Vol 11, No 1 (2015) | EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE | Abstract similar documents |
| K. B. Mirzaev, D. A. Andreev, D. A. Sychev | ||
| "... of clopidogrel, the association of residual platelet reactivity with clinical outcomes and a review ..." | ||
| Vol 7, No 1 (2011) | THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS | Abstract similar documents |
| O. V. Gaisenok | ||
| "... in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance ..." | ||
| Vol 7, No 1 (2011) | NEW ANTIPLATELET DRUGS (PART 1) | Abstract similar documents |
| A. B. Sumarokov | ||
| "... antiplatelet drugs are on their way to clinical application — prasugrel, ticagrelor, elinogrel, inhibitors ..." | ||
| Vol 7, No 1 (2011) | THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY | Abstract similar documents |
| V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev | ||
| "... Aim. To study therapeutic equivalence (efficacy, safety and tolerability) of original clopidogrel ..." | ||
| Vol 10, No 6 (2014) | СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY? | Abstract similar documents |
| S. Yu. Martsevich, A. Yu. Suvorov | ||
| "... Concomitant administration of clopidogrel and proton pump inhibitors (PPI), the possible influence ..." | ||
| Vol 3, No 3 (2007) | RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov | ||
| Vol 9, No 4 (2013) | THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE | Abstract similar documents |
| K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev | ||
| "... of the formation of the active clopidogrel metabolite, for efficacy and safety of this drug in cardiology practice ..." | ||
| Vol 6, No 4 (2010) | ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY? | Abstract similar documents |
| S. J. Martsevich | ||
| "... The ACC/AHA clopidogrel clinical alert about the possibility of ineffective treatment ..." | ||
| Vol 7, No 5 (2011) | NEW ANTIPLATELET DRUGS. PART 2 | Abstract similar documents |
| A. B. Sumarokov | ||
| "... are on their way to clinical application — prasugrel, ticagrelor , elinogrel, thromboxane receptor inhibitors ..." | ||
| Vol 12, No 4 (2016) | High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova | ||
| "... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..." | ||
| Vol 13, No 1 (2017) | MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE | Abstract similar documents |
| N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya | ||
| Vol 7, No 3 (2011) | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko | ||
| "... Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy ..." | ||
| Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
| A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
| "... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..." | ||
| Vol 5, No 5 (2009) | EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi | ||
| "... and morphology of erythrocytes and to assess their changes during therapy with acetylsalicylic acid, emclopidogrel/em ..." | ||
| Vol 8, No 2 (2012) | UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev | ||
| "... Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + emclopidogrel/em ..." | ||
| Vol 14, No 1 (2018) | NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev | ||
| "... effect of emclopidogrel/em, thus changing efficacy and safety of its standard dose. Aim. To study the impact ..." | ||
| Vol 14, No 5 (2018) | Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case | Abstract similar documents |
| M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov | ||
| "... for resistance to antiplatelet therapy with emclopidogrel/em. The decrease in the effectiveness of prolonged therapy ..." | ||
| Vol 15, No 2 (2019) | The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention | Abstract similar documents |
| A. S. Tereshchenko, E. V. Merkulov, A. N. Samko, S. A. Abugov | ||
| "... is emclopidogrel/em. It has been proven that the use of emclopidogrel/em to date not always reduces the risk of development ..." | ||
| Vol 9, No 1 (2013) | POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova | ||
| "... and induced flow cytofluorometry during antiplatelet therapy with emclopidogrel/em and acetylsalicylic acid (ASA ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... , warfarin, ticlopidine and emclopidogrel/em are discussed. Study data on new antiplatelet drugs are given ..." | ||
| Vol 7, No 5 (2011) | HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY | similar documents |
| G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio | ||
| "... Введение. Полученные ранее данные свидетельствуют о наличии у emклопидогрела/em не только ..." | ||
| Vol 11, No 4 (2015) | INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION | Abstract PDF (Eng) similar documents |
| K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev | ||
| "... of emclopidogrel’s/em active metabolite and, respectively, its antiplatelet effect. We sought to determine the impact ..." | ||
| Vol 7, No 6 (2011) | PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES | Abstract similar documents |
| R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova | ||
| "... , and emclopidogrel/em was not prescribed. At the same hospital clotting time was determined for monitoring of heparin ..." | ||
| Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract similar documents |
| D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
| "... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and emclopidogrel/em resistance ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and emclopidogrel/em and clinical ..." | ||
| Vol 8, No 2 (2012): | РЕКОМЕНДАЦИИ ПО ЛЕЧЕНИЮ ОСТРОГО КОРОНАРНОГО СИНДРОМА БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST | Abstract similar documents |
| , , , , , , , , , , , , , , , , | ||
| Vol 19, No 3 (2023) | Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro, A. V. Kapytski | ||
| "... 1565C), ITGA2 (C807T), eNOS3 (T786C) genes with high residual platelet reactivity (HRPR) to emclopidogrel/em ..." | ||
| Vol 10, No 5 (2014) | DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov | ||
| "... .8% of patients also received combination of emclopidogrel/em and acetylsalicylic acid, but changed medicinal products ..." | ||
| Vol 9, No 6 (2013) | THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) | Abstract similar documents |
| V. A. Sulimov | ||
| "... by half in patients aged ≥75 years) in combination with emclopidogrel/em and enoxaparin followed by admission ..." | ||
| Vol 9, No 6 (2013) | THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | Abstract similar documents |
| A. V. Shulkin, E. N. Yakusheva, N. M. Popova | ||
| "... ), encoding P-glycoprotein, in pharmacotherapy with digoxin, antiplatelet drugs (emclopidogrel/em tikagrelol ..." | ||
| Vol 21, No 2 (2025) | Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case) | Abstract similar documents |
| A. V. Melekhov, S. V. Borisovskaya, N. S. Gavrilina, I. I. Gaponova, I. G. Nikitin, O. A. Ettinger | ||
| "... . The widespread use of high-intensity statin therapy, often accompanied by the simultaneous use of emticagrelor/em ..." | ||
| Vol 7, No 4 (2011) | VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY | Abstract similar documents |
| L. A. Haisheva, S. V. Shlyk | ||
| "... of revealed disorders with antiplatelet agent — emclopidogrel/em 75 mg/day. Material and methods. 40 patients ..." | ||
| Vol 11, No 2 (2015) | CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE | Abstract similar documents |
| K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva | ||
| "... antiplatelet drugs (acetylsalicylic acid and emclopidogrel/em) and heparin. There were not any reasons ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... + emclopidogrel/em) can be prescribed to elderly patients with cardiovascular comorbidity who are deemed unsuitable ..." | ||
| Vol 20, No 5 (2024) | Postmyocardial syndrome after myocardial infarction and percutaneous coronary intervention | Abstract similar documents |
| A. A. Klimenko, N. A. Demidova, V. V. Veselkin, T. A. Kirdyashkina, A. A. Chinova, Yu. A. Shandanovina | ||
| "... . Hospital treatment was carried out with colchicine, methylprednisolone, acetylsalicylic acid, emticagrelor/em ..." | ||
| Vol 7, No 6 (2011) | CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM | Abstract similar documents |
| Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov | ||
| "... therapy (acetylsalicylic acid, emclopidogrel/em, warfarin) was made on the 4th day of disease onset taking ..." | ||
| Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
| I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
| "... with ASA and emclopidogrel/em, risk of thrombotic events is saved in ASA resistant patients with ACS ..." | ||
| Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
| A. V. Panov | ||
| "... antithrombotic therapy, preference should be given to emclopidogrel/em compared to other, more powerful P2Y12 ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... as between the groups of clopidogrelsensitive and emclopidogrel/em-resistant patients. No association between ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... . 51.8% of respondents recommend a combination of acetylsalicylic acid and emclopidogrel/em ..." | ||
| Vol 14, No 3 (2018) | APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova | ||
| "... in trials and proven efficacy in the prevention of stroke/systemic embolism, the use of emclopidogrel/em ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... pharmacies. Among antiplatelet agents, aspirin was available in most pharmacies, and emclopidogrel/em was mostly ..." | ||
| Vol 14, No 6 (2018) | Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice | Abstract PDF (Eng) similar documents |
| K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova | ||
| "... (3.8%) patients. Aspirin was the only antiplatelet agent in 3 cases and emclopidogrel/em – in one case ..." | ||
| Vol 14, No 1 (2018) | COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman | ||
| "... receptors (AMCR), diuretics, oral anticoagulants, emclopidogrel/em increased (p0.05). In the structure ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... with emclopidogrel/em (up to 5.4%) was registered at the second stage of the study. Over a five-year period bisoprolol ..." | ||
| Vol 12, No 5 (2016) | Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention | Abstract similar documents |
| E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva | ||
| "... antiplatelet therapy with acetyl salicylic acid and emclopidogrel/em. Numerous clinical characteristics ..." | ||
| Vol 9, No 1 (2013) | OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap | ||
| "... : antiplatelet agents – in 60.4% of the cases (584 patients received acetylsalicylic acid and 20 – emclopidogrel/em ..." | ||
| Vol 16, No 5 (2020) | Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register | Abstract similar documents |
| I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova | ||
| "... .8% – emclopidogrel/em, 91.1% – anticoagulants, 91.6% – beta-blockers, 95.6% – statins, 94.2% – angiotensin-converting ..." | ||
| Vol 16, No 2 (2020) | LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period | Abstract similar documents |
| S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh | ||
| "... of use of acetylsalicylic acid, emclopidogrel/em, statins, beta-blockers, ACE inhibitors, angiotensin II ..." | ||
| Vol 15, No 3 (2019) | Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery | Abstract similar documents |
| A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein | ||
| "... +emclopidogrel/em (75 mg/day). The aggregation study was performed with an optical aggregometer, using 5 μM ..." | ||
| Vol 11, No 6 (2015) | RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD) | Abstract similar documents |
| D. B. Nemick, G. V. Matyushin, A. V. Protopopov, S. A. Ustyugov, A. V. Shulmin | ||
| "... болезнью легких (ХОБЛ). Влияние ХОБЛ на течение острого инфаркта миокарда с подъемом сегмента ST (emИМпST/em ..." | ||
| Vol 17, No 1 (2021) | Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease | Abstract similar documents |
| S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova | ||
| "... /emclopidogrel/em/oral anticoagulants – 95,7%, statins/ezetimibe – 86,3%, angiotensin-converting enzyme inhibitors ..." | ||
| Vol 14, No 4 (2018) | Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment | Abstract similar documents |
| Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova | ||
| "... подъемом сегмента ST (emИМпST/em), в то же время желудочковые аритмии (ЖА) могут не только сопровождаться ..." | ||
| Vol 7, No 2 (2011) | COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE | Abstract similar documents |
| V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko | ||
| "... инфаркте миокарда с подъемом ST (emИМпST/em), в том числе догоспитального тромболизиса с применением ..." | ||
| Vol 11, No 5 (2015) | Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders | Abstract similar documents |
| B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov | ||
| "... Цель. Изучить клиническое течение острого инфаркта миокарда (ИМ) с подъемом сегмента ST (emИМпST/em) и ..." | ||
| Vol 5, No 6 (2009) | PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES | Abstract PDF (Eng) similar documents |
| O. V. Reshetko, N. V. Furman, R. M. Magdeev, Ya. P. Ya.P. Dovgalevskiy | ||
| "... Цель. Анализ тромболитической терапии инфаркта миокарда с подъемом сегмента SТ (emИМПST/em) на ЭКГ в ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION ON CEREBRAL HEMODYNAMICS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (THE RESULTS OF OBSERVATIONAL STUDIES) | Abstract similar documents |
| V. E. Kulikov, M. Je. Hapman, P. A. Barov, M. A. Toneeva, V. A. Sergievskaja | ||
| "... церебральной гемодинамики у пациентов в остром периоде инфаркта миокарда с подъемом сегмента ST (emИМПST/em ..." | ||
| Vol 12, No 2 (2016) | LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION | Abstract similar documents |
| N. E. Zakirova, Z. A. Kazieva, A. N. Zakirova | ||
| "... ) с подъемом (emИМпST/em) и без подъема сегмента ST (ИМбпST). Материал и методы. Обследованы 99 больных ..." | ||
| Vol 6, No 2 (2010) | EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION | Abstract PDF (Eng) similar documents |
| A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova | ||
| "... периоде инфаркта миокарда с подъемом сегмента ST (emИМПST/em). Материал и методы. В моноцентровое, открытое ..." | ||
| Vol 20, No 5 (2024) | Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM | Abstract similar documents |
| T. S. Sukhinina, M. A. Terenicheva, R. G. Gulyan, R. M. Shakhnovich, O. V. Stukalova, O. A. Saygina, I. S. Yavelov, D. V. Pevsner | ||
| "... миокарда с подъемом сегмента ST (emИМпST/em) в реальной клинической практике в России по данным регистра РЕГИОН ..." | ||
| Vol 14, No 4 (2018) | Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region | Abstract similar documents |
| S. A. Naumov, N. S. Karpunina | ||
| "... подъемом сегмента ST (emИМпST/em) на территории Пермского края, его эффективность и безопасность. Материал и ..." | ||
| Vol 17, No 3 (2021) | Evaluation of Procalcitonin Levels in Patients with Various Forms of Acute Coronary Syndrome, Depending on the Presence of Adverse Hospital Outcomes | Abstract similar documents |
| O. M. Drapkina, V. A. Zakharova | ||
| "... диагностирован у 47 (40,5%) пациентов с ИМ, а ИМ с подъемом ST (emИМпST/em) – у 69 (59,5%) пациентов с ИМ. В каждой ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... (emИМпST/em). Материал и методы. В одноцентровое открытое проспективное контролируемое исследование включено ..." | ||
| Vol 6, No 1 (2010) | PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya | ||
| "... ЭКГ (emИМпST/em), выявить изменение данных показателей под действием тромболитической терапии (ТЛТ ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE | Abstract similar documents |
| E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov, V. V. Bobkov, D. Yu. Platonov | ||
| "... пациентов с инфарктом миокарда с подъемом сегмента ST (emИМпST/em) при фармакоинвазивном подходе в условиях ..." | ||
| Vol 14, No 3 (2018) | ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| D. B. Nemik, G. V. Matyushin, S. A. Ustyugov | ||
| "... Летальность больных с острым инфарктом миокарда с подъемом сегмента ST (emИМпST/em) зависит от ..." | ||
| Vol 12, No 3 (2016) | EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD) | Abstract PDF (Eng) similar documents |
| D. B. Nemik, G. V. Matyushin, A. V. Protopopov, A. V. Shulmin, S. A. Ustyugov | ||
| "... Цель. Оценить влияние пола на летальность при инфаркте миокарда с подъемом сегмента ST (emИМпST/em ..." | ||
| Vol 18, No 4 (2022) | Impact of the COVID-19 Pandemic on Myocardial Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation | Abstract PDF (Eng) similar documents |
| B. G. Alekyan, S. A. Boytsov, V. I. Ganyukov, E. M. Manoshkina | ||
| "... пациентов с диагнозом ОКСбпST (на 29,03%). При этом поступление в клиники больных с emИМпST/em сократилось только ..." | ||
| Vol 18, No 6 (2022) | What is changing in the treatment of acute coronary syndrome in the Russian Federation? | Abstract similar documents |
| S. A. Boytsov, B. G. Alekyan, R. M. Shakhnovich, V. I. Ganyukov | ||
| "... ) (на 29,03%). При этом поступление больных с инфарктом миокарда с подъемом сегмента ST (emИМпST/em ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... (emИМпST/em). Материал и методы. В исследование было включено 386 пациентов с emИМпST/em. Пациенты основной группы ..." | ||
| Vol 20, No 5 (2024) | Gender differences in survival and its predictors in patients after myocardial infarction: data analysis from the RIMIS register | Abstract similar documents |
| O. S. Afonina, S. Yu. Martsevich, A. V. Zagrebelnyy, D. P. Sichinava, O. M. Drapkina | ||
| "... сегмента ST (emИМПST/em), и сравнить влияние повторного ИМ на отдаленную выживаемость у мужчин и женщин ..." | ||
| Vol 15, No 2 (2019) | Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction | Abstract similar documents |
| A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh | ||
| "... -сосудистых событий и состояния пациентов, перенесших год назад emИМпST/em и фармако-инвазивную реперфузию, в ..." | ||
| Vol 15, No 1 (2019) | Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction | Abstract PDF (Eng) similar documents |
| Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy | ||
| "... (emИМпST/em), подходящих для проведения ПЧКВ и разделенных в соотношении 1:1 на две группы: в группе А ..." | ||
| Vol 19, No 4 (2023) | Predictors of recurrent cardiovascular events in patients with a single-vessel coronary artery disease after ST-segment elevation myocardial infarction | Abstract similar documents |
| V. E. Oleynikov, E. V. Averyanova, A. A. Tonkoglaz, M. V. Lukyanova | ||
| "... инфаркт миокарда с подъемом сегмента ST (emИМпST/em), имеющих гемодинамически значимый стеноз только в инфаркт ..." | ||
| Vol 16, No 6 (2020) | Role of Speckle Tracking in the Evaluation of Left Ventricular Remodeling After Streptokinase Infusion in Patients with Acute Anterior Myocardial Infarction | Abstract PDF (Eng) similar documents |
| Sh. I. Farag, Kh. E. El-Rabbat, M. A. El-Awadi, A. M. Sabry | ||
| "... ). Материал и методы. В исследование было включено 200 пациентов с впервые развившимся острым передним emИМпST/em ..." | ||
| Vol 15, No 2 (2019) | Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin | ||
| "... пациентов, выписанных на амбулаторный этап наблюдения после emИМпST/em Проведено 4 визита (V): V1 - визит ..." | ||
| Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
| M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
| "... 75,6% (n=31) больных основной группы (р0,0001). ИМ с подъемом ST (emИМпST/em) зарегистрирован в 39,0% (n ..." | ||
| 1 - 90 of 90 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
